Fexofenadine: Uses, Side Effects, Dosage - Drugvu

ℹ️ Compiled from public regulatory records · Last regulator revision: May 22, 2026🚩 Report this page

Fexofenadine

Other Antihistamines For Systemic Use

GB MHRAUS FDA

Drug class: Other Antihistamines For Systemic Use
Availability: Over-the-counter
Routes: Oral
Markets covered: 2
Products on record: 53

R06AXOther Antihistamines For Systemic Use

Overview

Fexofenadine is an active pharmaceutical ingredient in the Other Antihistamines For Systemic Use group (R06AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	43	May 22, 2026
US United States	FDA	10	December 26, 2025

GBUnited Kingdom· MHRA

43 products

Uses

GBOfficial regulatory label· revised November 28, 2025[1]

Fexofenadine hydrochloride 120 mg is indicated in adults and children 12 years and older for the relief of symptoms associated with seasonal allergic rhinitis.

How to take

USUnited States· FDA

10 products

Uses

USOfficial regulatory label· revised December 19, 2025[2]

Uses reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.

How to take

Drug interactions

Known interactions involving Fexofenadine. Select one for details. This list is informational and not a complete interaction checker.

Aluminum Hydroxide Apalutamide Bempedoic Acid Berotralstat Brigatinib Cabozantinib Candida Albicans Capmatinib Coccidioides Immitis Spherule Daclatasvir Darolutamide Dronedarone Elagolix Eliglustat Eltrombopag Eluxadoline Enasidenib Encorafenib Entrectinib Enzalutamide Erdafitinib Flibanserin Fostamatinib Fostemsavir Gilteritinib Glasdegib Histamine Ibrutinib Isavuconazonium Istradefylline Ivacaftor Lasmiditan Ledipasvir Letermovir Lomitapide Lonafarnib Lorlatinib Magaldrate Magnesium Carbonate Magnesium Hydroxide Midostaurin Neratinib Nilotinib Pitolisant Ponatinib Quinapril Rifampin Rolapitant Sarecycline Sorafenib Teriflunomide Tolvaptan Tucatinib Ulipristal Vemurafenib Venetoclax Clarithromycin Clotrimazole Erythromycin Fluconazole Hyaluronidase Itraconazole Ketoconazole Miconazole Troleandomycin Voriconazole Abacavir Acarbose Acetaminophen Acetazolamide Acitretin Acyclovir Adapalene Albuterol Alendronate Alfuzosin Allopurinol Almotriptan Alosetron Alprazolam Alprostadil Amantadine Ambrisentan Amiloride Amiodarone Amitriptyline Amlodipine Amoxicillin Amphetamine Anastrozole Aprepitant Aripiprazole Aspirin Atazanavir Atenolol Atomoxetine Atorvastatin Azathioprine Azelastine Azithromycin Baclofen Benazepril Betaxolol Bimatoprost Bisoprolol Bortezomib Bosentan Brimonidine Brinzolamide Budesonide Bumetanide Bupropion Buspirone Butorphanol Caffeine Calcitriol Calcium Chloride Capecitabine Captopril Carbamazepine Carboplatin Carisoprodol Carvedilol Cefaclor Cefadroxil Cefazolin Cefdinir Cefepime Cefpodoxime Cefprozil Ceftriaxone Cefuroxime Celecoxib Cephalexin Cerivastatin Cetirizine Chlordiazepoxide Chlorhexidine Chlorothiazide Chlorpheniramine Chlorthalidone Ciclopirox Cimetidine Cinacalcet Ciprofloxacin Cisplatin Citalopram Clindamycin Clobetasol Clomipramine Clonazepam Clonidine Clopidogrel Clozapine Cyclobenzaprine Cyclophosphamide Cyclosporine Cytarabine Dapsone Darifenacin Desloratadine Desvenlafaxine Dexamethasone Dextromethorphan Diazepam Diclofenac Dicyclomine Didanosine Diflunisal Digoxin Diltiazem Dipyridamole Docetaxel Dofetilide Dolasetron Donepezil Doxazosin Doxepin Doxorubicin Doxycycline Duloxetine Dutasteride Efavirenz Eletriptan Enalapril Entacapone Epinephrine Eplerenone Epoprostenol Erlotinib Estradiol Etodolac Etoposide Exemestane Ezetimibe Famciclovir Famotidine Felodipine Fenofibrate Fentanyl Finasteride Flecainide Flunisolide Fluocinonide Fluorouracil Fluoxetine Flurazepam Fluticasone Fluvastatin Fluvoxamine Folic Acid Formoterol Fosamprenavir Fosinopril Furosemide Gabapentin Galactose Galantamine Gatifloxacin Gefitinib Gemcitabine Gemfibrozil Gemifloxacin Gentamicin Glimepiride Glipizide Glyburide Goserelin Granisetron Haloperidol Heparin Hydrochlorothiazide Hydrocortisone Hydromorphone Hydroxychloroquine Hydroxyurea Hydroxyzine Ibandronate Ibuprofen Iloprost

Showing 240 of 461. Type above to find a specific drug.

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]MHRA (UK) · PL157640169 · revised November 28, 2025
[2]FDA DailyMed · 00ef8467-30a0-75… · revised December 19, 2025 [PDF]

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.

Side effects & warnings

GBOfficial regulatory label· Adverse reactions· revised November 28, 2025[1]

The following frequency rating has been used, when applicable:
Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders Common: headache, drowsiness, dizziness Eye disorders Not known: Vision blurred Gastrointestinal disorders Common: nausea General disorders and administration site conditions Uncommon: fatigue In adults, the following undesirable effects have been reported in post-marketing surveillance.
The frequency with which they occur is not known (can not be estimated from available data): Immune system disorders hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis Psychiatric disorders insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria) Cardiac disorders tachycardia, palpitations Gastrointestinal disorders diarrhoea Skin and subcutaneous tissue disorders rash, urticaria, pruritus Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

GBOfficial regulatory label· Warnings and precautions· revised November 28, 2025[1]

As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. 2). 8). Fexofenadine hydrochloride tablets contains sodium This medicine contains less than 1mmol sodium (23mg) per tablet, that is to say essentially sodium free.

This is not medical advice. Consult a qualified healthcare professional.